Estimating Event Rates Using the Medication Cohort Module: Hypertension and Negative Control Outcomes in New Users of Onabotulinumtoxin A and Monoclonal Antibodies Targeting the Calcitonin-Gene-Related Pathway in the Marketscan EarlyView Claims Database (20200218)

23/04/2020
19/03/2021
EU PAS number:
EUPAS34832
Study
Finalised
Documents
Study protocol
Initial protocol
English (628.94 KB - PDF) View document
Study results
Study results
English (63.97 KB - PDF) View document
Study report
Other information